Search research articles
Contact Us
Filters
Showing results (801-810 of 843) with videos related to
Page
of 85
Sort By:
Journal of Medicinal Chemistry
|
November 28, 2006
Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1
Francis X Tavares, Kamal A Al-Barazanji, Eric C Bigham, et al.
European Urology
|
January 31, 2012
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification
Shahrokh F Shariat, Richard Zigeuner, Michael Rink, et al.
European Urology
|
January 7, 2014
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma
Daniel J Lee, Evanguelos Xylinas, Malte Rieken, et al.
Iscience
|
June 24, 2022
The origin of bladder cancer from mucosal field effects
Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
March 1, 2026
[Pathogen spectrum characteristics and influencing factors of recurrent respiratory infection in children in the Shenzhen community during winter and spring]
D D Niu, Z Zhang, N X Chen, et al.
Scientific Reports
|
January 20, 2017
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
Aaron Mobley, Shizhen Zhang, Jolanta Bondaruk, et al.
Iscience
|
July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effects
Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2006
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
Donald L Hertzog, Kamal A Al-Barazanji, Eric C Bigham, et al.
Urology
|
November 4, 2009
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer
Marco Roscigno, Shahrokh F Shariat, Massimo Freschi, et al.
NPJ Digital Medicine
|
January 24, 2025
V3+ extends the V3 framework to ensure user-centricity and scalability of sensor-based digital health technologies
Jessie P Bakker, Roland Barge, Jacob Centra, et al.
Page
of 85
Search research articles
Search
Showing results (801-810 of 843) with videos related to
Sort By:
Page
of 85
Journal of Medicinal Chemistry
|
November 28, 2006
Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1
Francis X Tavares, Kamal A Al-Barazanji, Eric C Bigham, et al.
European Urology
|
January 31, 2012
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification
Shahrokh F Shariat, Richard Zigeuner, Michael Rink, et al.
European Urology
|
January 7, 2014
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma
Daniel J Lee, Evanguelos Xylinas, Malte Rieken, et al.
Iscience
|
June 24, 2022
The origin of bladder cancer from mucosal field effects
Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
March 1, 2026
[Pathogen spectrum characteristics and influencing factors of recurrent respiratory infection in children in the Shenzhen community during winter and spring]
D D Niu, Z Zhang, N X Chen, et al.
Scientific Reports
|
January 20, 2017
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
Aaron Mobley, Shizhen Zhang, Jolanta Bondaruk, et al.
Iscience
|
July 11, 2022
Erratum: The origin of bladder cancer from mucosal field effects
Jolanta Bondaruk, Roman Jaksik, Ziqiao Wang, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2006
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists
Donald L Hertzog, Kamal A Al-Barazanji, Eric C Bigham, et al.
Urology
|
November 4, 2009
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer
Marco Roscigno, Shahrokh F Shariat, Massimo Freschi, et al.
NPJ Digital Medicine
|
January 24, 2025
V3+ extends the V3 framework to ensure user-centricity and scalability of sensor-based digital health technologies
Jessie P Bakker, Roland Barge, Jacob Centra, et al.
Page
of 85